Tag: Johnson & Johnson

Weekly Update

Weekly Market Overview – August 3-August 9, 2026

Palantir impresses with strong growth. The UMBRELLA strategy also focuses on healthcare, European defense, and structural trends.
Continue Umbrella
Weekly Update

Weekly Market Overview – August 17-August 23, 2026

Healthcare and AI provided support in a mixed week, while European defense stocks and SpaceX were more under pressure. There
Continue Umbrella
Weekly Update

Weekly Market Overview – August 10-August 16, 2026

TKMS raises its outlook, SpaceX is added to the UMBRELLA strategy, thereby strengthening its focus on defense, AI, and the
Continue Umbrella
Weekly Update

Weekly Market Overview – July 27-August 2, 2026

The market overview shows why strong figures from Apple, Rheinmetall, and other companies are not always enough for price gains.
Continue Umbrella
Weekly Update

Weekly Market Overview – July 20-26, 2026

Tesla is at the center of the earnings season following its Q2 results. The UMBRELLA Strategy is selling the position
Continue Umbrella
Weekly Update

Weekly Market Overview – July 13-19, 2026

IBM's earnings warning rattles the stock markets. Why fundamental data, quarterly results, and company outlooks are once again the most
Continue Umbrella
Johnson & Johnson
Healthcare
USA

Valuation Analysis: Johnson & Johnson

Johnson & Johnson is one of the world's leading healthcare companies. The company benefits from a strong position in pharmaceuticals
Active icon
Continue Umbrella
Johnson & Johnson
Healthcare
USA

Stock: Johnson & Johnson

Thanks to a strong pipeline, robust cash flows and a defensive business model, Johnson & Johnson remains a high-quality healthcare
Active icon
Continue Umbrella
MUMAK SpotLight

MUMAK SpotLight of the week: Eli Lilly and Palantir in focus

Eli Lilly strengthens its pipeline, Palantir remains volatile, and Johnson & Johnson gains momentum. The most important developments of the
Continue Umbrella
RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: Johnson & Johnson – Breakout Drawing Closer?

Johnson & Johnson shows operational strength and a constructive chart picture. The resistance at $273–274 now comes into focus.
Continue Umbrella
RED HOT CHILI™ MUMAK

RED HOT CHILI MUMAK of the Week: Johnson & Johnson – Technical Chart Picture Brightens Significantly

Following strong quarterly figures, a raised annual guidance, and a further improvement in the chart setup, Johnson & Johnson receives
Continue Umbrella
Weekly Update

Weekly Market Overview – June 15-21, 2026

The UMBRELLA Strategy is divesting from energy stocks and further expanding its engagement in the healthcare and biotechnology sector.
Continue Umbrella